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   In dogs anesthetized with sodium pentobarbital, adrenaline and norad-
renaline in the portal and hepatic vein were estimated by using a fluorimetric 
method after the administration of mixed each 100µg/kg of adrenaline and 
noradrenaline. Four groups of experiments were performed in the present 
study as follow; (1) Intact dogs (2) Carbon tetrachloride intoxicated dogs 
(CCl4-dogs) (3) Chloroform intoxicated dogs (CHCl3-dogs) (4) Dogs with 
obstructive jaundice due to common bile duct ligation (Jaundice dogs) 
   In intact dogs, the reduction rate of catecholamine in the liver 1 minute 
after the administration of adrenaline and noradrenaline was over 70.1% 
for adrenaline and 56.1% for noradrenaline. Then the reduction rate of 
adrenaline was higher than that of noradrenaline. The content of catechol-
amine was markedly reduced at 3 minutes, and the reduction rate was 
less at 3 minutes than at 1 minute. 
   In dogs with severe damaged liver such as CCl4-dogs and CHCl3-dogs, 
the reduction rate of catecholamine in the liver was lowered markedly 
about 10 to 30%, and a highly significant difference was found between 
this group and intact group. In jaundice dogs with the moderate damaged 
liver, the figure was between the above two groups. 
   Levels of S-GOT and S-GPT were inversely proportional to the reduc-
tion rate of adrenaline and noradrenaline in the liver. 
   In intact dogs the glucose from the liver began to release between 1 
and 3 minutes after the catecholamine infusion and showed as peak at 7 
minutes. On the other hand, in CCl4-dogs and CHCl3-dogs the glucose 
output from the liver was not occured. In jaundice dogs the glucose 
output from the liver was found, but less than in intact dogs. 
   It is concluded that the liver would reduce a large amount of ad-
renaline and noradrenaline and the reduction rate would vary in proportion 
to the degree of damage to the liver.
*乗富　智
                  INTRODUCTION 
   Many investigators have studied the liver as an important organ 
to inactivate catecholamine, since ATHANASIU and LANGL.OIS1) showed 
that the effect of intravenously injected extract of suprarenal medulla 
on the blood pressure was prolonged considerably when the liver was 
excluded from the circulation. 
   PHILPOT and CANTONI14) demonstrated that adrenaline injected into 
the portal vein raised the blood pressure to a much smaller degree 
than when injected into the jugular vein. In order to achieve a rise of 
blood pressure when making the injection into the portal vein, a 4 to 
5 times larger amount of adrenaline is needed if it is injected into the 
femoral vein, while a 10 times larger amount is required in TANI's'9 
early experiment. 
   Recently, in order to study the role of the liver in the metabolic 
inactivation of circulating adrenaline and noradrenaline, HERTTING et 
al.11' and HAZELRIG et al.10' observed the metabolites of dl-7- epi-
nephrine-H3 and dl-norepinephrine-C14 in the bile and urine of rats 
following their administration. 
   However, there have been no investigations with relation to the 
elimination of catecholamine in the liver by means of the determination 
of the content of adrenaline and noradrenaline in portal and hepatic 
venous blood after the administration of catecholamine in vivo. 
   In the present study, the amount of adrenaline and noradrenaline 
in plasma of portal and hepatic venous blood after the administration 
of a large amount of adrenaline and noradrenaline was fluorimetrically 
determined at timed intervals, in order to find the amount of adrenal-
ine and noradrenaline before and after passing through the liver, and 
the reduction rate of these two substances in the intact and damaged 
liver. 
             MATERIALS AND METHODS 
   47 adult mongrel dogs of both sexes, weighing from 10 to 15 kg, 
were used in the present study. The animals were anesthetized by 
intravenous injection of 25mg/kg of sodium pentobarbital (Nembutal, 
Abbott). 
   In order to collect the blood samples, the catheterization of the 
portal vein was done by using a small polyethylene tube through an 
abdominal approach, and the catheterization of the hepatic vein was
done in the left common hepatic vein by the method of Shoemaker et 
al. 18' . Heparin solution in a dose of 1000 U/1 ml was used as an anti-
coaglant. As a rule, observations were started about one hour after 
the operation. 
   Mixed each 100.'g/kg of adrenaline and noradrenaline (Sankyo-
Seiyaku Co,) was injected into the femoral vein in 5 to 7 seconds. 5 to 8 
ml of portal and hepatic venous blood for estimation of adrenaline and 
noradrenaline were taken in the portal and hepatic vein at 1 minute 
and 3 minutes intervals following the administration of catecholamine. 
   Blood samples were immediately centrifuged for 10 minutes at 3000 
r. p. m., and 1 ml of plasma was mixed with 1 ml of sodium fluolide-
sodium thiosulphate solution according to WEIL-MALHERBE and BONE. 20) 
Then, the fluorimetric method of EULER and LISHAJKO6) was applied for 
determination of adrenaline and noradrenaline. Fluorometry was carried 
out using a Farrand Fluorometer (Model A). 
   The following caluculation was made to obtain an approximate 
value for the reduction rate of adrenaline and noradrenaline in the 
liver; 
    P-H % decrease = CPP) x 100 
       P; Plasma catecholamine content in the portal vein. 
       H; Plasma catechlamine content in the hepatic vein. 
   The concentration of glucose in portal and hepatic venous blood 
before and 1,3,7,10, and 15 minutes after the injection of adrenaline 
and noradrenaline was estimated by the method of HAGEDORN and 
JENSEN. 9) 
   Hepatic temperature before and after the injection of catecholamine 
was measured at timed intervals by using Jintan Electro Clinical 
Thermometer (Model H-1). 
   Experiments were performed on four groups of dogs in the present 
study; (1) Intact dogs (2) Carbon tetracloride intoxicated dogs which 
had been injected 3 times with 1 ml/kg body weight of 50% CC14 olive 
oil solution at 3 day intervals intramuscularly and used in expriments 
at 2 days after the last injection (CC14 -dogs) . (3) Chloroform. intoxicated 
dogs which had been injected 2 times with 1 ml/kg of 25% CHC13 olive 
oil solution at 3 day intervals intramuscularly and used in experiments 
on the day after the last injection (CHCI3 -dogs) . (4) Jaundice dogs 
which had been used in experiments 10 days after the common bile 
duct ligation (Jaundice dogs). 
   Levels of serum glutamic oxalacetic transaminase (S-GOT) and 
serum glutamic pyruvic transaminase (S-GPT) were estimated by the 
method of REITMANN and FRANKELIS) with Hitachi Spectrophotometer. 
   After the experiments the liver was fixed with 10% formaline, 
stained with hematoxylin-eosin, then the grade of the damaged liver 
was confirmed-
                     RESULTS 
Intact dogs 
   After the administration of mixed each 100 ug/kg of adrenaline 
and noradrenaline the content of adrenaline and noradrenaline in plasma 
of portal venous, hepatic venous and femoral arterial blood and levels 
of S-GOT and S-GPT in 15 dogs are summarized in Table 1. 
   Plasma catecholamine content in portal venous blood 1 minute after 
the administration of catecholamine was 31-109 ug/dl for adrenaline 
and 31-125 ug/dl for noradrenaline, the average values of adrenaline 
and noradrenaline being 55.7±5.9 pg/dl (mean ± standard error of the 
mean) and 73.5±7.4 ,g/dl respectively. Plasma catecholamine content 
in hepatic venous blood 1 minute after the administration of catechol-
amine was 2 '29 ,ug/dl for adrenaline and 11.53 11g/dl for noradrenaline, 
the average values of adrenaline and noradrenaline being 15.5±1.8 
4ag/dl and 32.0±3.3 ug/dl respectively. The average value of P-H% 
decrease was 70.1±2.9% for adrenaline and 56.1±2.3% for noradrena-
line and there was statistically a highly significant difference between 
those of adrenaline and noradrenaline (p<0.01) (Fig.3). On the other 
hand, plasma catecholamine content in femoral arterial blood 1 minute 
after the administration of catecholamine in 5 cases was 37-v121 pg/dl 
for adrenaline and 46-v142 ug/dl for noradrenaline, the average values of 
adrenaline and noradrenaline being 70.0±15.3 ig/dl and 91.4±18.9 pg/dl 
respectively. Plasma content of adrenaline and noradrenaline in the 
femoral artery was higher than those of the portal vein in all cases. 
   At 3 minutes after the administration of catecholamine, plasma 
catecholamine content in portal venous, hepatic venous and femoral 
arterial blood was remarkably decreased, and plasma catecholamine 
content in portal venous blood was 7--25 pg/dl for adrenaline and 9-38 
ig/dl for noradrenaline, the average values of adrenaline and norad-
renaline being 13.0±1.3 ug/dl and 20.2±2.1 pg/dl respectively. In the 
hepatic vein, plasma catecholamine content was 1-12 ug/dl for adrena-
line and 3-20 ug/dl for noradrenaline, the average values of adrenaline 
and noradrenaline being 4.2±0.9 i g/dl and 9.8 ± 1.3 ,ug/dl respectively. 
The average value of P-H% decrease was 63.8±6.6% for adrenaline 
and 51.6±4.7% for noradrenaline. 
   As a typical experiment is shown in Fig. 1, the glucose concentration 
in portal and hepatic venous blood was changed following the adminis-
tration of adrenaline and noradrenaline. The glucose output from the 
liver was not found within 1 minute after the catecholamine infusion,
Table 1. Summary of plasma catecholamine content in portal venous. hepatic venous 
         and femoral arterial blood of intact dogs after the administration of mixed 
                     each 100 ug/kg of adrenaline and noradrenaline.
                     Plasma catecholamine content (ug/dl) after the 
          Body administration of adrenaline and noradrenaline.
 Exp.No. 
          we 1 min. 3 min.         ight F P H F I P H S -GOT SGPT  and sex 
       (kg) 
             A N A N A N A N A N A N 
  1 8 11.5 45 79 44 60 13 22 18 25 13 17 3 10 25 27 
  2 Y 13.5 121 142 80 105 26 50 26 34 12 30 11 12 5 36 
  3 15.0 86 61 65 93 21 27 23 16 11 13 3 7 18 50 
  4 8 14.8 37 46 36 38 18 18 8 10 7 9 1 3 36 39 
  5 8 1'0.2 61 129 48 92 11 42 18 21 15 17 4 12 23 9 
  6 8 12.3 51 57 16 20 7 10 1 4 20 44 
  7 8 14.0 54 73 19 28 12 18 5 12 38 25 
  8 Y 12.6 60 77 16 47 18 31 2 15 25 10 
  9 Y 12.0 31 60 9 28 13 15 1 4 1 30 
 10 6 11.3 38 54 10 25 11 18 3 4 30 19 
 11 Y 10.8 96 121 20 47 10 22 8 11 8 35 
 12 8 13. 0' 40 48 11 29 11 38 3 13 18 17 
 13 8 10.5 43 69 12 33 25 22 2 20 38 6 
 14 Y 11.0 41 31 2 11 8 1.5 4 6 17 27 
 15 6 14.1 109 125 29 53 22 28 12 14 3 13 
           A 170.0±15.3 55.7-5.9 15.6±1.8 18.6±3.1 13.0±1.3 4.2±0.9 Mean±s.e N '91.4±18.9 73.5±7.4~ 32 0±3.5I 21 2±4.7 20 2±2.1 9.8±1.3~ 
P-H% A 70.1±2.9 63.8±6.6 
   decrease N 56.1±2.3 51.6±4.7 
      A; Adrenaline 
       N; Noradrenaline s.e; Standard error of the mean 
      F; Femoral artery % (P-H) 
       P: Portal vein P-H % decrease = - P x 100 
      H; Hepatic vein
but the liver began to release the glucose 1 minute later. The glucose 
concentration in hepatic venous blood was 104 mg/dl before injection. 
It was rapidly increased to 170 mg/dl at 3 minutes and 208 mg/dl as 
peak at 7 minutes. On the other hand, the elevation of the glucose 
concentration in portal venous blood was later than that of hepatic 
venous blood and reached its peak at 180 mg/dl 10 minutes after the 
catecholamine infusion. 
   In all cases liver temperature was between 37.1°C and 39.3°C, 
showing an increase of 0.5°C within 3 minutes after the catecholamine 
infusion. Levels of S-GOT and S-GPT were observed under 50 U in all 
intact dogs.
Fig. 1. The glucose output from the liver after the administration of mixed each 
          100ag/kg of adrenaline and noradrenaline in the intact dog.
Carbon tetrachloride intoxicated, dogs (CCl4 -dogs) 
   After the administration of mixed each 100 ug/kg of adrenaline and 
noradrenaline the content of adrenaline and noradrenaline in plasma of 
portal and hepatic venous blood and levels of S-GOT and S-GPT in 13 
CC14_-dogs are summarized in Table 2. 
   Plasma catecholamine content in portal venous blood 1 minute after 
the administration of catecholamine was 27-96 ag/dl for adrenaline and 
40-144 Pg./dl for noradrenaline, the average values of adrenaline and 
noradrenaline being 58.8±6.5 ag/dl and 79.8±2.2 ug/dl respectively. 
Plasma catecholamine content in hepatic venous blood 1 minute after the 
administration of catecholamine was 21-96;y,g/dl for adrenaline and 26-
123 ug/dl for noradrenaline, the average values of adrenaline and nor-
adrenaline being 47.3±6.3 pg./dl and 65.5±8.1,aa /dl respectively. The 
average value of P-H% decrease was 20.7±3.1%, for adrenaline and 
18.7±3.1% for noradrenaline and a highly significant difference was 
found between P-H % decrease of intact dogs and CC14 -dogs (adrenal-
ine; P<0.01, noradrenaline; P<0.01) (Fig. 3). 
   At 3 minutes after the administration of catecholamine, plasma 
catecholamine content in portal venous blood was 6-40 ug/dl for ad-
renaline and 10-54 ,ag/dl for noradrenaline, the average values of ad-
renaline and noradrenaline being 19.9±2.7 ug/dl and 25.5±3.7 ag/dl
Table 2 Summary of plasma catecholamine content in portal and hepatic venous 
           blood of CC14-intoxicated dogs after the administration of mixed each
                  100 leg/kg of adrenaline and noradrenaline.
                       Plasma catecholamine content (ug/dl) 
                       after the administration of adrenaline
            Body and noradrenaline. Exp. No. 
           weight 1 min. 3 min. S-GOT S-GPT 
and sex (kg) - -
                  P H P H 
               A N A N A N A N i
16 6 11.0 66 82 39 60, 13 25 17 22 640 800 
17 a 10.5 53 79 48 80 19 19 10 16 1600< 1200< 
18 ? 12.8 90 113 74 98 24 28 24 27 1600< 1200` 
19 6 13.6 63 130 51 104 30 42 31 38 1040 1200< 
20 6 12.0 72 99 68 66 22 36 18 36 1600< 1200< 
21 ? 10.2 29 43 23 34 7 13 7 10 1400 1200< 
22 9 10.5 27 70 21 60 20 25 11 13 800 960 
23 6 11.2 40 57 34 56 16 36 6 30' 1600 1200< 
24 6 10.0 49 50 31 38 14 20 13 29 656 1080 
25 8 13.8 84 77 61 68 19 11 19 9 720' 1200< 
26 8 13.7 31 40 23 26 6 10 4 10 920 880 
27 ? 13.5 65 53 47 38 10 12 8 9 840 1056 
28 6 10.3 96 144 96 123 40 54 23 51 1600< 1200< 
Mean±s.e A 58.8±6.5 47.3±6.3 19.9±2.7 14.7±2.2                N 79 .8±9.2 65.5±8.1 25.5±3.7 1 23.1±3.7 
P.H % decrease A 20.7±3.1 24.5± 6.3                N 18 .7±3.1 10.2±5.8 
       A; Adrenaline 
       N; Noradrenaline s . e; Standard error of the mean 
       P; Portal vein P-H % decrease (P-11) = 
P x 100        H; H
epatic vein
respectively. In hepatic venous blood, plasma catecholamine content 
was 4---31pg/dl for adrenaline and 95,51 ug/dl for noradrenaline, the 
average values of adrenaline and noradrenaline being 14.7±2.2 .lg/dl 
and 23.1±3.7 .ig/dl respectively. The average value of P-H% decrease 
was 24.5±6.3% for adrenaline and 10.2±5.8% for noradrenaline and 
there was a highly significant difference between P-H% decrease of 
intact dogs and CC14-dogs (adrenaline; P`0.01, noradrenaline; p<0.01) 
(Fig. 4). 
   As a typical experiment is shown in Fig.2, the glucose output from 
the liver was not almost found after the catecholamine infusion. In 
CC14 -dogs liver temperature was between 37.5°C and 39.6°C, showing 
the increase of 0.4°C within 3 minutes after the catecholamine infusion. 
Serum transaminase levels were remarkably increased; S-GOT was over 
640 U and S-GPT was over 800 U. Histologically the liver cell showed 
central fatty degeneration and slight necrosis (Photo.1) .
Fig. 2. The glucose output from the liver after the administration of mixed each 
        100,tg/ kg of adrenaline and noradrenaline in the CC14-intoxicated dog.
Chloroform intoxicated dogs (CHCl3_dogs) 
   Results in CHC13-dogs were almost similar to those Of CC14 -dogs. 
   After the administration of mixed each 100,ug./kg of adrenaline and 
noradrenaline the content of adrenaline and noradrenaline in plasma of 
portal and hepatic venous blood and levels of S-GOT and S-GPT in 10 
CHC13 -dogs are summarized in Table 3. 
   Plasma catecholamine content in portal venous blood 1 minute after 
the administration of catecholamine was 32--100 ug/dl for adrenaline and 
46-114 /tg/dl for noradrenaline, the average values of adrenaline and nor-
adrenaline being 60.8 ± 6.5,ug/dl and 74.5 ± 5.8-ug/dl respectively. Plasma 
catecholamine content in hepatic venous blood 1 minute after the adminis-
tration of catecholamine was 21-95 l-,g/dl for adrenaline and 30-102 
,ug/dl for noradrenaline, the average values of adrenaline and nor-
adrenaline being 46.5 ± 7.0,ug/dl and 53.2±6.6 ug/dl respectively. The 
average value of P-H% decrease was 22.5±6.9%/ for adrenalinie and 
30.0±3.7% for noradrenalne. There was a highly significant difference 
between those of intact dogs and CHC13-dogs (adrenaline; P<0.01, 
noradrenaline; P<0.01) (Fig. 3). 
   At 3 minutes after the administration of catecholamine, plasma 
catecholamine content in portal venous blood was 7-42 pg/dl for adrenal-
Fig. 3. P-H% decrease of adrenaline and noradrenaline in the liver of dogs 1 minute 
                 after the administration of mixed each 100pg/kg of 
                          adrenaline and noradrenaline.
Fig. 4. P-H% decrease of adrenaline and noradrenaline in the liver of dogs 3 
              minutes after the administration of minxed each 100ug/kg of 
                           adrenaline and noradrenaline
Table 3. Summary of plasma catecholamine content in portal and hepatic venous 
        blood of CHCI3-intoxicated dogs after the administration of mixed each 
        100ug/kg of adrenaline and noradrenaline.
                       Plasma catecholamine content (ug/dl) 
                        after the administration of adrenaline
            Body and noradrenaline. Exp. No. - - - - -
           weight 1 min. 3 min. S-GOT S-GPT 
and sex -- -- ----- - -- -- -- - --         (kg) 
P H P H I 
                A N A N A N A N 
29 9 10.0 100 114 95 102 42 48 39 40 1600 1200< 
30 Y 10.2 46 60 42 42 18 31 12 24 1600< 1200 
31 8 11.5 82 89 59 64 29 35 24 28 1136 1120 
32 8 14.0 68 64 63 36 16 20 14 16 1600< 1200< 
33 8 13.6 42 72 21 36 24 24 11 15 936 792 
34 6 12.2 74 72 30 48 16 19 13 13 856 760 
35 8 12.4 32 46 32 30 7 10 3 6 1600< 1200 
36 8 12.0 56 68 54 58 12 13 7 7 1600< 1200< 
37 8 14.5 58 75 27 54 10 13 6 5 800 848 
38 8 10.8 50 85 1 42 62 8 22 6 16 1600< 980 
Mean ± s.e A 60.8-_6.5 46.5-7.0 18.2__3.4 I 13.5±3.4                 N 74 .5±5.8 53.2±6.6 23.5±3.7 17.0--3.5 
P-H% decrease A 22.5 6.9 30.7 5.5                   N 30 .0-_3.7 32.3-±4.5 
       A; Adrenaline 
       N; Noradrenaline s.e; Standard error of the mean 
      P; Portal vein P-H % decrease = (PP) x 100 
       H; Hepatic vein
ine and 10-48 ug/d1 for noradrenaline, the average values of adrenal-, 
ine and noradrenaline being 18.2 ± 3.4ug/dl and 23.5 ± 3.7ug/dl re-
spectively. Plasma catecholamine content in hepatic venous blood was 
3--39,ug/dl for adrenaline and 5--40 pg/dl for noradrenline, the average 
values of adrenaline and noradrenaline being 13.5 ± 3.4ug/dl and 17.0+ 
3.5ug/dl respectively. The average value of P-H% decrease was 30.7± 
5.5% for adrenaline and 32.3±4.5% for noradrenaline and there was a 
highly significant difference between P-H% decrease of intact dogs and 
CHC13-dogs (adrenaline; P`0.01, noradrenaline; P<0.01) (Fig. 4). 
   As a typical experiment is shown in Fig.5, the glucose output from 
the liver was almost not found after the catecholamine infusion as in CC14-
dogs. Liver temperature in CHC13 -dogs was between 37.7C° and 40.5 
°C , showing the increase of 0.3°C within 3 minutes after the catechol-
amine infusion. Serum transaminase levels were remarkably increased; 
S-GOT was over 800 U and S-GPT was over 760 U. Histologically the 
liver cell showed central fatty degeneration and slight necrosis (Photo.2).
Fig. 5. The glucsse output from the liver after the adrninistration of mixed each 
        100,ig/kg of adrenaline and noradrenaline in the CHCIa-intoxicated dog.
Dogs with obstructive jaundice due to common bile duct ligation (Jaun'lice dogs) 
   After the administration of mixed each 100,tg/kg of adrenaline and 
noradrenaline the content of adrenaline and noradrenaline in plasma of 
portal and hepatic venous blood and levels of S-GOT and S-GPT in 9 
 jaundice dogs are summarized in Table 4. 
   Plasma catecholamine content in portal venous blood 1 minute after 
the administration of catecholamine was 26- 92ug/dl for adrenaline and 
45. 129ug/dl for noradrenaline, the average values of adrenaline and 
noradrenaline being 58.2±7.8 tgldl and 82.7±8.8i-tg/dl respectively. 
Plasma catecholamine content in hepatic venous blood 1 minute after the 
administration of catecholamine was 11-51 ~g/dl for adrenaline and 
19- -72pg/dl for noradrenaline, the average values of adrenaline and 
noradrenaline being 28.2±4.7,g/dl and 44.1 ± 5. LL g/dl respectively. The 
average value of P-H% decrease was 52.3±3.3%a for adrenaline and 
46.6±2.7%/ for noradrenaline and a highly significant difference was 
found between P-H% decrease of intact dogs and jaundice dogs (P< 
0.01, P<0.05, respectively) (Fig. 3). 
   At 3 minutes after the administration of catecholamine, plasma 
catecholamine content in portal venous blood was 5. 31t g/dl for ad-
renaline and 5-36 ug/dl for noradrenaline, the average values of ad-
Table 4. Summary of plasma catecholamine content in portal and hepatic venous 
        blood of dogs with obstructive jaundice after the administration of mixed 
                     each 100fcg/kg of adrenaline and noradrenaline.
                       Palasma catecholamine content (iig/dl) 
                        after the administration of aerenaline
            Body noradrenaline. Exp. No. -
           weight lmin. 3min. S-GOT S-GOT 
and Sex (kg) - -- -
                   P H P H 
       
I A N A N A N A N 
39 8 13.2 26 49 14 28 5 28 1 9 1032 1200< 
40 ? 10.8 85 89 46 55 22 36 18 36 1560 600 
41 8 11.5 51 99 17 44 9 18 2 16 288 568 
42 6 14.0 75 78 31 40 15 9 21 9 488 460 
43 9 10.4 37 99 22 49 17 5 11 1 760 1200< 
44 Y 10.1 34 45 11 19 - - - - 540 698 
45 6 12.6 92 129 51 72 31 8 18 8 632 880 
46 12.3 66 91 35 46 19 23 12 26 816 632 
47 8 12.6 58 65 27 44 - - - - 640 810 
Mean =s.e A 58.2±7.8 28.2±4.7 16.9±3.2 1 11.9_±3.0 
                  N 82.7_8.8 44.1_5.1 18.1--L-4.4 15.0- 4.6 
P-H% decrease A 52.3 ±3.3 35.7±15.3                N 46
.6±2.7 20.9- 14.0 
      A; Adrenaline 
       N; Noradrenaline s. e; Standard error of the mean 
      P; Portal yein P-H % decrease = (Pp) x 100 
      H ; Hepatic vein
renaline and noradrenaline being 16.9±3.2 ug/dl and 18.1 ± 4.4,ug/dl re-
spectively. In hepatic venous blood, plasma catecholamine content was 
1-21 ug/dl for adrenaline and 1- 36.ug/dl for noradrenaline, the average 
values of adrenaline and noradrenaline being 11.9±3.0,ug/dl and 15.0± 
4.6i- g/dl respectively. The average value of P-H °o decrease was 35.7 
±15.3% for adrenaline and 20.9±14.0%1 for noradrenaline. 
   As a typical experiment is shown in Fig. 6, the glucose output from 
the liver was not found within 1 minute after the catecholamine infu-
sion, but the liver began to release the glucose 1 minute later. It 
showed a similar pattern to intact dogs, but the glucose concentration 
in portal and hepatic venous blood of jaundice dogs was less elevated 
than that of intact dogs. Liver temperature was between 37.1°C and 
38.8°C, showing the increase of 0.5°C within 3 minutes after the 
catecholamine infusion, which was the same pattern of change as in 
the above two groups. Histologically the liver showed congestion in 
the sinusoid, but the degeneration and necrosis in the liver cell could 
not clearly be found (Photo. 3) .
Fig. 6. The glucose output from the liver after ;the administration of mixed each 
              100ug/kg of adrenaline and noradrenaline in the dog 
                          with obstructive jaundice.
Correlation between P-H% decrease and serum transaminase levels 
Correlation between P-H% decrease and serum transaminase levels 
as in Fig. 7-10, such as S-GOT levels and P-H% decrease of adrenal-
ine, S-GOT levels and those of noradrenaline, S-GPT levels and those 
of adrenaline, and S-GPT levels and those of noradrenaline, were 
shown in inverse correlation in the present study (r = - 0.664, r = -
0.555,r= - 0.672, r= - 0.563,) (Fig. 7,8,9,10.). 
                   DISCUSSION 
   It has been well established that the liver is an important organ 
to inactivate catecholamine'.2.3.4.5.'.1°.1'.13.14.19) This was confirmed in 
vivo more directly in the present study by using a fluorimetric method. 
   In this study, neither the content of catecholamine in the hepatic 
artery nor blood flow of portal vein and hepatic artery was measured, 
but the catecholamine content of femoral arterial blood was not 
less than that of portal venous blood. It is assured that, when the 
amount of adrenaline being 55.7 ± 5.9,ug/dl and noradrenaline being 
73.5±7.4ig/dl in plasma of portal venus blood, adrenaline and norad-
Fig.. 7. Correlation between P-H% decrease of adrenaline after the 
           administration of catecholamine and S-GOT
renaline are eliminated over 70.1±2X% and 56.1±2X/0 respectively 
through the liver in the intact dog at 1 minute after the administration 
of mixed each 100,ug/kg of adrenaline and noradrenaline, and a differ-
ence between the reduction rate of adrenaline and noradrenaline is 
statistically highly significant. The content of cetacholamine in portal 
venous blood ai 3 minutes after the catecholamine infusion was reduced 
to about 1/3 times of that in 1 minute, and the reduction rate of 
catecholamine in the liver would be varied in accordance with the 
content of circulating catecholamine. 
   BAIN and BATTY3)studied, in vitro, the half-inactivation times of 
adrenaline and noradrenaline by human liver slices, which were 15.5 
minutes for adrenaline and 12.25 minutes for noradrenaline, being 
against to my present study. On the other hand, the result of the 
present study harmonized with that of Blaschko et a1.4' who experi-
mented with extract of the liver of guinea-pig. 
   By perfusing an isolated liver of rabbit, LUND13' showed that blood 
containing 400f.'g i/ of adrenaline and I mg % of noradrenaline was 
almost completly cleared passing through the liver, showing a higher 
inactivation function of the liver than in this study.
Fig. 8. Correlation between P-H % decrease of noradrenaline after 
         the administration of catecholamine and S-GOT
   The result of the present study is similar to CARLSSON and WALDECK5> 
who investigated the uptake of noradrenaline in the heart and skeletal 
muscle after the administration of H3-noradrenaline intraperitoneally 
and C14-noradrenaline intravenously. The uptake of intraperitoneally 
administered noradrenaline in the heart and skeletal muscle was about 
30% of the intravenons route. 
   HERTTING and LABROSSE11> concluded that the liver plays a very 
important role in the metabolic inactivation of circulating epinephrine 
following the administration of dl-epinephrine-7-H3 to rat with biliary 
fistulas, in which 10% of the injected tritium after intrajugular in-
fusion and 31% after intraportal infusion was excreted in the bile. 
   More recently, HAZELRIG et al1°'. administered dl-norepinephrine-C14 
to rat with biliary fistulas via the tail vein or the portal vein. When 
it was injected into the tail vein, only 10% of the injected C14 was 
excreted in the bile in contrast to 22.3% after the intraportal infusion. 
The study of HERTTING and LABROSSE11> , HAZELRIG et al'0'. , and this 
experiment indicate that the reduction rate of adrenaline in the liver 
is higher than that of noradrenaline,
Fig. 9. Correlation between P-H% decrease of adrenaline after the 
           administration of catecholamine and S-GPT
   Other investigators showed that adrenaline injected into the portal 
vein has a much smaller effect in raising blood pressure than when 
injected into the femoral vein. Thus, all the other studies mentioned 
above, using the indirect method, suggest that the liver is a most 
important organ to inactivate catecholamine. The result of the present 
study using the direct method demonstrated clearly the role of the 
liver to inactivate catecholamine after the administration of catechol-
amine, agreeing well with the other findings mentioned above. 
   The glucose from the intact liver after the administration of ad-
renaline and noradrenaline began to release between 1 and 3 minutes 
and reached a maximum at 7 minutes. This was slightly late in com-
parison with the result of SHOEMAKER and FINDER171 who injected only 
adrenaline. 
   Since there is no available information on the reduction of cate-
cholamine in the damaged liver, the second series of this experiment 
was carried out to follow up the reduction rate of catecholamine in the 
damaged liver. 
   In our previous study 111, it was suggested that the reduction
Fig. 10. Correlation between P-H% drecrease of noradrenaline after the 
              administration of catechloamine and S-GPT
rate of catecholamine in the damaged liver decreases in proportion to 
the degree of damage. In M,-dogs, the reduction rate of adrenaline 
and noradrenaline 1 minute after the administration of mixed each 100 
pg/kg of both was remarkably lowered to 20.7% and 18.7% respectively, 
and a difference between intact dogs and CC14-dogs was highly sig-
nificant. 
   In CHC13 -dogs, the reduction rate of catecholamine was also lowered 
to 22.5% for adrenaline and 30.0% for noradrenaline, the figure being 
similar to that of M,-dogs. It would then appear that the degree of 
damage to the liver in both groups was equally severe. 
   In jaundice dogs, the figure was between the intact group and the 
above two groups, the reduction rate of adrenaline being 52.3% and 
norderenaline being 46.6%, with the degree of damage to the liver 
being moderate. 
   JOLY et al M . determined catechloamine levels in portal and hepatic 
venous blood in portal hypertension. They reported that hepatic venous 
blood contained significantly less noradrenaline than portal venous 
blood, and strongly suggested a hepatic clearance of noradrenaline in
their conclusion. In contrast, there was no difference between ad-
renaline levels in portal venous blood and in hepatic venous blood. 
As their experiments were done with very low catecholamine levels, 
their findings were slightly different from the results of the present 
study. In the present study which was done with exceedingly high cate-
cholmine levels, it seems to be the same fate of circulating adrenaline 
and noradrenaline in the liver. These findings are supported by many 
other workers who have reported the fate of circulating catecholamine 
in the liver. 
   GOODALL et al". studied the metabolic product of noradrenaline in 
the urine after the intravenous injection of dl-noradrenaline-C14 in 4 
patients with portal (alcoholic) cirrhosis, and their results seemed to 
indicate that noradrenaline metabolism is altered in the patient with 
portal cirrhosis. They suggested that catecholamine metabolism in the 
liver is changed in the patient with liver disease. This was confirmed 
clearly in the present study. 
   Levels of S-GOT and S-GPT and the reduction rate of catecholamine 
in the liver showed an inverse correlation in the present study. Thus, 
it is concluded that adrenaline and noradrenaline are reduced signifi-
cantly in the liver, i.he reduction rate changing in proportion to the 
degree of damage to the liver
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Photo 1. 
Tne liver of CC14-dog, showing 
central fatty degeneration and 
slight necrosis. (Dog 18, H-E 
stain)
Photo 2.. 
The liver of CHC13-dog., showing 
central fatty degeneration and 
slight necrosis. (Dog 29, H-E 
staih)
Photo. 3.. 
Th .e liver of Jaundice dog, show-
ing congestion in the sinusoid. 
(Dog 45, H-E stain)
